FDA Declares IV Fluid Shortage in the Wake of Helene

The FDA has declared a shortage of three critical intravenous drugs—Dextrose 70% IV Solution, Lactated Ringers IV Solution, and Peritoneal Dialysis Solution—following the shutdown of Baxter International's North Carolina manufacturing plant due to Hurricane Helene. These solutions are vital for patient rehydration and support in kidney failure treatment.

 

The FDA's declaration allows hospital pharmacies more flexibility to prepare alternative solutions while conserving existing supplies. Baxter is working to mitigate disruptions, with full production recovery expected by year-end. In the meantime, other manufacturers are increasing output, and temporary imports from Baxter’s overseas facilities have been authorized to alleviate the crisis. Read more in The Hill here.